Why is California’s hospice industry facing heightened enforcement and scrutiny?
California is a major focus of hospice fraud investigations. Regulators have revoked more than 280 hospice licenses in the last four years.
What federal oversight actions is CMS using to address hospice fraud risk?
CMS launched the Provisional Period of Enhanced Oversight (PPEO) for new hospices on July 13, 2023. CMS also expanded prepayment medical review in 2024 to more high-risk states.
What compliance expectations should California hospice providers prepare to meet right now?
Expect unannounced site visits, validation surveys, and deeper documentation review. Records should clearly support eligibility, including required face-to-face encounters.
Why does California’s hospice fraud crisis matter to providers in other states?
California is influencing national program integrity strategy and analytics. Providers in other states may face prepayment review or probes based on risk signals, not location.
What practical steps can hospice organizations take to reduce audit and enforcement risk?
Strengthen governance, ownership transparency, internal controls, and audit ready documentation. Tighten marketing, referral, and consent processes.
California’s hospice sector is under the most intense scrutiny in the United States. State officials report more than 280 hospice license revocations in the last four years, reflecting a coordinated crackdown that now spans multiple agencies and levels of government.
The scale of the issue is visible in Los Angeles County’s data. Hospice agencies increased by 1,589% from 2010 to 2022, reaching 1,841 providers. Regulators have documented dense clusters of agencies registered at the same address, a well-recognized indicator of potential fraud. These trends prompted CMS to intensify federal involvement, including, the Provisional Period of Enhanced Oversight (PPEO) for new hospices beginning July 13, 2023, and the expansion of prepayment medical review in 2024 to several additional high‑risk states.
Despite a statewide moratorium on new hospice licenses and tighter state licensing rules, media investigations found that Medicare continued certifying hospices in high‑risk environments, underscoring the gap between federal certification and state licensure controls.
Enforcement has also become more targeted and forensic, with high-profile cases including a $54 million scheme, demonstrating the sophistication and scale of fraudulent activity uncovered in this environment.
California has become the national focal point for hospice fraud enforcement and the testing ground for the regulatory strategies that are beginning to influence oversight at the federal level.
What This Means If You Operate in California
For hospice providers in California, heightened oversight is now a constant reality. Regulators are applying deeper, faster and more frequent scrutiny, and CMS’ use of the PPEO increases the likelihood of prepayment review soon after enrollment or following ownership changes. This means providers must be prepared to demonstrate compliance readiness at any point, not just during scheduled audits.
Unannounced site visits and validation surveys have also become more common, with reviewers examining not only documentation but the operational backbone of an organization: staffing, service delivery, governance and patient engagement. In this environment, documentation must be clear, consistent and defensible, with every certification, face‑to‑face encounter and clinical narrative supporting eligibility.
Regulators are also placing far greater emphasis on ownership transparency and operational legitimacy. Providers can expect deeper inquiries into ownership structures, management arrangements and related‑party relationships, particularly where past patterns have raised red flags. At the same time, marketing practices, referral pathways, and patient consent processes are subject to closer examination due to prior abuses across the state.
Given this environment, operating in California requires a proactive and highly disciplined approach to compliance. Providers that invest in strong governance, reliable documentation and operational rigor will be better positioned to withstand continued scrutiny and maintain reliable, high‑quality care delivery.
If You Don’t Operate in California, Why Does This Still Matter?
California’s hospice oversight model has become the blueprint for how federal agencies are shaping their national enforcement strategies. In response to similar patterns of rapid market expansion and questionable operational behavior, CMS has already expanded enhanced oversight measures, including prepayment medical review, to other states including Arizona, Nevada, Texas, Georgia and Ohio. The data irregularities that triggered intervention in Los Angeles such as unusual utilization trends, complex ownership structures and irregular billing practices now guide CMS analytics across the country. As a result, hospices in historically low‑scrutiny regions can be flagged based solely on their operational profile, regardless of geographic risk. Being identified may lead to actions such as prepayment review, targeted probes, site visits or broader program integrity investigations.
California’s crackdown is shaping national expectations around ownership transparency and patient protection. Regulators nationwide are now paying closer attention to absentee owners, rapid license transfers, related‑party arrangements and recruitment practices that may compromise informed consent. This shift means providers everywhere should anticipate more detailed examination of Change of Ownership (CHOW) activity, along with their marketing practices, referral sources and consent procedures. Even compliant organizations may experience more questions about how patients are approached, how hospice benefits are explained and how eligibility is established.
The future of hospice oversight is being shaped by how federal and state regulators have responded to the fraud uncovered in California. The enforcement tools, data‑driven methodologies and cross‑agency coordination developed in response to California’s crisis are now influencing national oversight standards. As these approaches are adopted more broadly, hospices across the country should expect more aggressive audits, shorter documentation timelines and higher expectations for clinical defensibility and operational integrity. Providers that strengthen their compliance posture now will be best positioned to navigate this evolving landscape, no matter where they operate.
How We Can Help
In today’s environment, hospice providers should view rising oversight not as a regional concern but as a clear indication that higher standards are becoming the norm across the industry. Strengthening internal controls, elevating documentation practices and ensuring your data is both accurate and audit-ready are essential to maintaining operational stability and safeguarding patient trust. By proactively investing in compliance infrastructure now, organizations can navigate increasing scrutiny with confidence, protect their mission and continue delivering compassionate, patient-centered care without interruption. If you need help navigating compliance, please contact Denise Gaulin.
